Patent ID: 9345679
Filing Date: 2016-05-24
CPC Classification: A61K,A61P

Claim Text:
1. A method of treating low magnesium levels in a mammal, the method comprising: administering to the mammal a therapeutically effective amount of magnesium salt in an oral dosage form, the oral dosage form comprising magnesium lactate from about 80% to about 95% by weight of the dosage form and one or more excipients present from about 5% to about 20% by weight of the dosage form, the oral dosage form having an uncoated core dissolution profile under the Tablet Dissolution Test characterized by no more than about 40% by weight magnesium salt released at 1 hour, at least about 50% by weight magnesium salt released at 6 hours, and at least about 85% by weight magnesium salt released at 10 hours.